Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner

Raquel Guillamat Prats, Martina Rami, Larisa Ring, Petteri Rinne, Estelle Lauer, Sebastien Lenglet, Aurelien Thomas, Sabrina Pagano, Nicolas Vuilleumier, Benjamin F. Cravatt, Christian Weber, Alexander Faussner, Sabine Steffens*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)348-351
Number of pages4
JournalThrombosis and Haemostasis
Volume119
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • ACTIVATED ENDOCANNABINOID SYSTEM
  • MONOGLYCERIDE LIPASE
  • CELLS
  • ATHEROSCLEROSIS
  • METABOLISM
  • BLOCKADE

Cite this

Prats, R. G., Rami, M., Ring, L., Rinne, P., Lauer, E., Lenglet, S., Thomas, A., Pagano, S., Vuilleumier, N., Cravatt, B. F., Weber, C., Faussner, A., & Steffens, S. (2019). Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner. Thrombosis and Haemostasis, 119(2), 348-351. https://doi.org/10.1055/s-0038-1676769